Biotech and pharmaceutical companies ranked by market capitalization, from the diversified giants to clinical stage bets. This is the sector where a single trial readout can double a company or halve it, and where the winners compound for decades.
Combined market cap $3.36T.
| # | Company | Price | 24h | Market cap | P/E | 30d |
|---|---|---|---|---|---|---|
| 1 | $1,220.51 | +0.45% | $1.15T | 42.4 | ||
| 2 | $260.86 | +0.41% | $628.65B | 30.5 | ||
| 3 | $248.66 | -0.57% | $439.33B | 127.1 | ||
| 4 | $132.93 | +1.92% | $328.31B | 36.8 | ||
| 5 | $416.18 | +0.45% | $224.62B | 26.0 | ||
| 6 | $135.87 | +0.07% | $168.69B | 17.4 | ||
| 7 | $26.31 | -1.16% | $149.95B | 18.7 | ||
| 8 | $525.73 | -0.74% | $133.43B | 28.1 | ||
| 9 | $797.99 | +0.12% | $82.21B | 15.4 | ||
| 10 | $208.87 | +2.44% | $30.86B | 21.7 | ||
| 11 | $63.67 | +5.12% | $25.26B | -6.8 |